Activation by malaria antigens renders mononuclear cells susceptible to HIV infection and re-activates replication of endogenous HIV in cells from HIV-infected adults

Parasite Immunology

Volumn 26, Issue 5, 2004, Pages 213-217

  Froebel, K ^a   Howard, W ^a   Schafer, J R ^a   Howie, F ^a   Whitworth, J ^b   Kaleebu, P ^b   Brown, A L ^a   Riley, E ^a,c  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

HIV; Malaria; Plasmodium falciparum

Indexed keywords

ANTIGEN; MALARIA ANTIGEN; PARASITE ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENDEMIC DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGICAL PARAMETERS; IN VITRO STUDY; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALARIA; MALARIA CONTROL; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VIROGENESIS; VIRUS LOAD; VIRUS PATHOGENESIS; VIRUS REACTIVATION; VIRUS REPLICATION; VIRUS STRAIN;

ADULT; ANIMALS; ANTIGENS, PROTOZOAN; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HUMANS; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; MALARIA, FALCIPARUM; MIDDLE AGED; PLASMODIUM FALCIPARUM; T-LYMPHOCYTES; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; PLASMODIUM FALCIPARUM; PROTOZOA; RNA VIRUSES;

EID: 7444228087     PISSN: 01419838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0141-9838.2004.00701.x     Document Type: Article

References (12)

1. Bentwich Z, Maartens G, Torten D, Lal AA & Lal RB. Concurrent infections and HIV pathogenesis. AIDS 2000; 14: 2071-2081.
2. Riley EM. Is T cell priming required for initiation of pathology in malaria infections? Immunol Today 1999; 20: 228-233.
3. Spina C, Prince H & Richman D. Preferential replication of HIV-1 in the CD45RO memory cell subset of primary CD4 lymphocytes in vitro. J Clin Invest 1997; 99: 1774-1785.
4. Chandramohan D & Greenwood BM. Is there interaction between human immunodeficiency virus and Plasmodium falciparum? Int J Epidemiol 1998; 27: 296-301.
5. Rowland-Jones S & Lohman B. Interactions between malaria and HIV infection - an emerging public health problem? Microbes Infect 2002; 4: 1265-1270.
6. Xiao L, Owen SM, Rudolph DL, Lal RB & Lal AA. Plasmodium falciparum antigen-induced human immunodeficiency virus type 1 replication is mediated through induction of tumour necrosis factor-alpha. J Infect Dis 1998; 177: 437-445.
7. Rhee M & Riley E. Changes in cytokine production associated with acquired immunity to Plasmodium falciparum malaria. Clin Exp Immunol 2001; 126: 503-510.
8. Kaleebu P, Yirrell D, French N, et al. An improved algorithm for determining HIV Type 1 subtypes in a primary laboratory in Uganda. AIDS Res Human Retroviruses 2000; 16: 621-625.
9. Kaleebu P, French N, Mahe C, et al. Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda. J Infect Dis 2002; 185: 1244-50.
10. Morgan D, Mahe C, Mayanja B, Okongo JM, Lubega R & Whitworth JA. HIV-infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries? Aids 2002; 16: 597-603.
11. UNAIDS Reference Group on Estimates, Modelling and Projections. Improved methods and assumptions for estimation of the HIV/AIDS epidemic and its impact: Recommendations of the UNAIDS Reference Group on Estimates, Modelling and Projections. Aids 2002; 16: W1-W14.
12. Pori G, Kinter AC, Justement JS, Bressler P, Kehrl JH & Fauci AS. Transforming growth factor beta suppresses human immunodeficiency virus expression and replication in infected cells of the monocyte macrophage lineage. J Exp Med 1991; 173: 589-597.